Prognosis
Covid-19 Pill Clears FDA; New York Cases Climb; Virus Update
This article is for subscribers only.
Merck & Co.’s Covid-19 pill was cleared by U.S. regulators, the second new treatment option approved in as many days in an expanding arsenal to fight the pandemic. But just like testing sites and vaccines, treatment pills will be in short supply for months until production can increase.
New York’s daily coronavirus cases nearly doubled in less than a week when the state broke the previous record. Meanwhile, Morgan Stanley told workers to wear masks and limit big meetings.